CTI BioPharma Corp.
(NASDAQ : CTIC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -5.17%45.850.0%$286.15m
HZNPHorizon Therapeutics Plc -3.75%99.845.4%$179.80m
VRXValeant Pharmaceuticals International, Inc. 1.11%23.7214.1%$139.57m
CTLTCatalent, Inc. -4.16%122.342.0%$139.08m
ICLRICON plc -0.09%272.812.8%$113.67m
JAZZJazz Pharmaceuticals Plc -1.99%120.262.1%$75.13m
UTHRUnited Therapeutics Corp. -1.74%185.9913.9%$72.82m
PRGOPerrigo Co. Plc -0.17%35.776.9%$61.33m
BHCBausch Health Cos., Inc. 1.11%23.720.0%$61.23m
ARGXargenx SE -3.80%283.700.0%$57.55m
CPIXCumberland Pharmaceuticals, Inc. 8.77%4.590.6%$53.98m
ENDPEndo International Plc -5.49%4.998.5%$43.65m
IRWDIronwood Pharmaceuticals, Inc. -1.17%10.989.5%$25.02m
PCRXPacira Biosciences, Inc. -2.27%52.539.8%$24.33m
AXSMAxsome Therapeutics, Inc. -3.33%32.241.8%$22.43m

Company Profile

CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.